Analyst Rating Changes — Upgrades, Downgrades & Price Targets

42988 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.

Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.

All ↑ Upgrades ↓ Downgrades ◎ Price Targets

Latest Rating Changes

When	Stock	Change	Firm	Analyst	Rating	Price Target
Sep 23 00:12 UTC	CLDX Celldex Therapeutics	◎ Target	Cantor Fitzgerald	Kristen Kluska ★☆☆☆☆ #3071	Overweight	$61.00→ $72.00+18.0%
Sep 23 00:12 UTC	CHRD Chord Energy	◎ Target	UBS Group	Josh Silverstein ★★★☆☆ #1493	Buy	$189.00→ $184.00-2.6%
Sep 23 00:12 UTC	CCL Carnival	◎ Target	TD Cowen	Kevin Kopelman ★★★☆☆ #1486	Buy	$34.00→ $32.00-5.9%
Sep 23 00:12 UTC	BPOP Popular	◎ Target	Citigroup	Benjamin Gerlinger not yet tracked	Buy	$200.00→ $192.00-4.0%
Sep 23 00:12 UTC	BOOT Henry Boot	◎ Target	Berenberg Bank	firm only	Buy	GBX 219→ GBX 186-15.1%
Sep 23 00:12 UTC	BMNR BitMine Immersion Technologies	◎ Target	B. Riley Financial	Fedor Shabalin ★★☆☆☆ #2386	Buy	$30.00→ $34.00+13.3%
Sep 23 00:12 UTC	AXS Accsys Technologies	◎ Target	Canaccord Genuity Group	firm only	Buy	GBX 130→ GBX 120-7.7%
Sep 23 00:12 UTC	ASST Strive	◎ Target	B. Riley Financial	Fedor Shabalin ★★☆☆☆ #2386	Buy	$26.00→ $33.00+26.9%
Sep 23 00:12 UTC	AQN Algonquin Power & Utilities	◎ Target	Canadian Imperial Bank of Commerce	firm only		C$6.25→ C$6.00-4.0%
Sep 23 00:12 UTC	APH Amphenol	◎ Target	BNP Paribas Exane	Andrew Buscaglia ★★☆☆☆ #2287	Outperform	$107.50→ $110.00+2.3%
Sep 23 00:12 UTC	ANIX Anixa Biosciences	◎ Target	HC Wainwright	Yi Chen ★★☆☆☆ #2598	Buy	$7.00→ $6.00-14.3%
Sep 23 00:12 UTC	AMRZ Amrize	◎ Target	UBS Group	Julian Radlinger ★★☆☆☆ #2347	Neutral	$57.00→ $42.00-26.3%
Sep 23 00:12 UTC	ALKS Alkermes	◎ Target	Robert W. Baird	Joel Beatty ★★★☆☆ #2056	Outperform	$58.00→ $61.00+5.2%
Sep 23 00:12 UTC	ADPT Adaptive Biotechnologies	◎ Target	BTIG Research	Mark Massaro ★★★★★ #172	Buy	$25.00→ $34.00+36.0%
Sep 23 00:12 UTC	ACO.X ATCO	◎ Target	Canadian Imperial Bank of Commerce	firm only		C$88.00→ C$85.00-3.4%
Sep 23 00:12 UTC	ABVX Abivax	◎ Target	Truist Financial	Gregory Renza ★★★☆☆ #1651	Buy	$155.00→ $151.00-2.6%
Sep 23 00:12 UTC	ABVX Abivax	◎ Target	Wedbush	David Nierengarten ★★☆☆☆ #2626	Neutral	$140.00→ $118.00-15.7%
Sep 23 00:12 UTC	AA Alcoa	◎ Target	Freedom Broker	Vitaly Kononov ★★★☆☆ #1671	Buy	$64.00→ $76.00+18.8%
Sep 23 00:12 UTC	REPYY Repsol	↓ Downgrade	Santander	firm only	Outperform→ Neutral
Sep 23 00:12 UTC	NFLX Netflix	↓ Downgrade	HSBC	Mohammed Khallouf ★★★☆☆ #1313	Buy→ Hold	$96.00→ $76.00-20.8%
Sep 23 00:12 UTC	EXK Endeavour Silver	↓ Downgrade	Canadian Imperial Bank of Commerce	firm only	Outperform→ Neutral
Sep 23 00:12 UTC	ERIC Ericsson	↓ Downgrade	Morgan Stanley	Terrance Tsul not yet tracked	Equal Weight→ Underweight	$11.00→ $9.00-18.2%
Sep 23 00:12 UTC	DAVA Endava	↓ Downgrade	William Blair	Maggie Nolan ★★★★☆ #592	Market Perform→ Underperform
Sep 23 00:12 UTC	CMPX Compass Therapeutics	↓ Downgrade	Wedbush	Robert Driscoll ★★☆☆☆ #2507	Neutral	$1.00
Sep 23 00:12 UTC	BRBY Burberry Group	↓ Downgrade	Royal Bank Of Canada	firm only	Sec→ r perform	GBX 1,400→ GBX 1,200-14.3%
Sep 23 00:12 UTC	BEAT HeartBeam	↓ Downgrade	HC Wainwright	Yi Chen ★★☆☆☆ #2598	Buy→ Neutral
Sep 23 00:12 UTC	BCAX Bicara Therapeutics	↓ Downgrade	HSBC	firm only	Equal Weight
Sep 23 00:12 UTC	WST West Pharmaceutical Services	↑ Upgrade	Morgan Stanley	Kallum Titchmarsh ★★★★★ #79	Equal Weight→ Overweight	$365.00→ $400.00+9.6%
Sep 23 00:12 UTC	VLEEY Valeo	↑ Upgrade	Jefferies Financial Group	firm only	Hold→ Buy
Sep 23 00:12 UTC	RNR RenaissanceRe	↑ Upgrade	Jefferies Financial Group	firm only	Hold→ Market Outperform
Sep 23 00:12 UTC	QNCX Quince Therapeutics	↑ Upgrade	Citizens Jmp	Jonathan Wolleben ★★☆☆☆ #2594	Market Perform→ Outperform	$77.00
Sep 23 00:12 UTC	QNCX Quince Therapeutics	↑ Upgrade	Citigroup	firm only	Market Perform→ Outperform
Sep 23 00:12 UTC	OMER Omeros	↑ Upgrade	Cantor Fitzgerald	Olivia Brayer Saunders not yet tracked	Neutral→ Overweight	$22.00
Sep 23 00:12 UTC	MET MetLife	↑ Upgrade	Piper Sandler	Paul Newsome ★★★★★ #195	Neutral→ Overweight	$99.00→ $110.00+11.1%
Sep 23 00:12 UTC	HFWA Heritage Financial	↑ Upgrade	Brean Capital	firm only	Neutral→ Buy	$33.00
Sep 23 00:12 UTC	FITB Fifth Third Bancorp	↑ Upgrade	Citigroup	Benjamin Gerlinger not yet tracked	Neutral→ Buy	$59.00→ $62.00+5.1%
Sep 23 00:12 UTC	EPM Evolution Petroleum	↑ Upgrade	Freedom Broker	Sergey Pigarev ★★★★★ #271	Hold→ Buy	$4.50
Sep 23 00:12 UTC	ELD Eldorado Gold	↑ Upgrade	Bank of America	firm only	Underperform→ Buy	C$32.00→ C$54.00+68.8%
Sep 23 00:12 UTC	EGO Eldorado Gold	↑ Upgrade	Bank of America	Lawson Winder ★★★☆☆ #1691	Underperform→ Buy	$32.00→ $54.00+68.8%
Sep 23 00:12 UTC	EAT Brinker International	↑ Upgrade	Northcoast Research	Jim Sanderson not yet tracked	Neutral→ Buy	$275.00
Sep 23 00:12 UTC	DANOY Danone	↑ Upgrade	Deutsche Bank Aktiengesellschaft	firm only	Sell→ Hold
Sep 23 00:12 UTC	CWK Cranswick	↑ Upgrade	Berenberg Bank	firm only	Buy	GBX 5,770→ GBX 6,080+5.4%
Sep 23 00:12 UTC	AM Antero Midstream	↑ Upgrade	Capital One Financial	firm only	Equal Weight→ Overweight	$25.00
Sep 22 23:12 UTC	CMPX Compass Therapeutics	↓ Downgrade	Wedbush	Robert Driscoll ★★☆☆☆ #2507	Neutral	$1.00
Sep 22 22:12 UTC	CMPX Compass Therapeutics	↓ Downgrade	Wedbush	firm only	Neutral
Sep 22 19:12 UTC	TA TransAlta	◎ Target	Canadian Imperial Bank of Commerce	firm only		C$26.00→ C$24.50-5.8%
Sep 22 19:12 UTC	STAA STAAR Surgical	◎ Target	Jefferies Financial Group	Young Li ★★☆☆☆ #2685	Buy	$28.00→ $23.00-17.9%
Sep 22 19:12 UTC	H Hydro One	◎ Target	Canadian Imperial Bank of Commerce	firm only		C$59.00→ C$56.00-5.1%
Sep 22 19:12 UTC	FTS Fortis	◎ Target	Canadian Imperial Bank of Commerce	firm only		C$82.00→ C$78.00-4.9%
Sep 22 19:12 UTC	EMA Emera	◎ Target	Canadian Imperial Bank of Commerce	firm only		C$76.00→ C$72.00-5.3%

🔒 38 more rating changes on this page — plus filtering by our own analyst accuracy.

A free account unlocks the full daily feed.

Frequently Asked Questions

What are analyst rating changes?

An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.

How is this feed different from other rating trackers?

Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.

How often is the rating-changes feed updated?

The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.

Do analyst upgrades and price-target increases mean I should buy?

No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.

Analyst Rating Changes — Upgrades, Downgrades & Price Targets

Latest Rating Changes

Frequently Asked Questions

Welcome to 13Foresight!